HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nausicaa Clemente Selected Research

Inflammation (Inflammations)

10/2022The Gut-Ex-Vivo System (GEVS) Is a Dynamic and Versatile Tool for the Study of DNBS-Induced IBD in BALB/C and C57BL/6 Mice, Highlighting the Protective Role of Probiotics.
3/2021Gut-Ex-Vivo system as a model to study gluten response in celiac disease.
1/2017Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis.
1/2017Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nausicaa Clemente Research Topics

Disease

16Neoplasms (Cancer)
01/2024 - 01/2017
7Melanoma (Melanoma, Malignant)
11/2022 - 01/2018
5Multiple Sclerosis
06/2021 - 09/2014
4Breast Neoplasms (Breast Cancer)
10/2023 - 01/2020
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2022 - 09/2014
4Inflammation (Inflammations)
10/2022 - 01/2017
3Neoplasm Metastasis (Metastasis)
01/2024 - 10/2020
3Autoimmune Diseases (Autoimmune Disease)
01/2016 - 02/2014
2Liver Diseases (Liver Disease)
11/2023 - 11/2021
2Carcinoma (Carcinomatosis)
10/2023 - 09/2020
2Congenital Structural Myopathies (Centronuclear Myopathy)
01/2022 - 12/2019
2Wounds and Injuries (Trauma)
01/2022 - 04/2018
2Cardiotoxicity
01/2020 - 11/2019
2Proteinuria
06/2015 - 09/2014
2Autoimmune Lymphoproliferative Syndrome
02/2014 - 05/2012
1Sarcopenia
04/2024
1Muscular Atrophy (Muscle Atrophy)
04/2024
1Osteoporosis
04/2024
1Fibrosis (Cirrhosis)
11/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Ischemia
01/2022
1Rare Diseases (Rare Disease)
01/2022
1Multiple Myeloma
01/2022
1Sepsis (Septicemia)
01/2022
1Neoplasm Micrometastasis
12/2021
1Reperfusion Injury
11/2021
1Fatty Liver
11/2021
1Alzheimer Disease (Alzheimer's Disease)
06/2021
1Nervous System Diseases (Neurological Disorders)
06/2021
1Chronic Disease (Chronic Diseases)
03/2021
1Cystic Fibrosis (Mucoviscidosis)
03/2021
1Celiac Disease (Celiac Sprue)
03/2021
1Experimental Melanoma
10/2020
1Hyperthermia
09/2020
1Peripheral Nervous System Diseases (PNS Diseases)
02/2020

Drug/Important Bio-Agent (IBA)

12OsteopontinIBA
12/2021 - 09/2014
6CytokinesIBA
04/2024 - 02/2014
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2020
3Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 01/2019
3Interleukin-10 (Interleukin 10)IBA
10/2020 - 09/2014
2Monoclonal AntibodiesIBA
10/2023 - 11/2019
2RNA (Ribonucleic Acid)IBA
10/2023 - 07/2019
2Nicotinamide PhosphoribosyltransferaseIBA
10/2023 - 01/2020
2Drug CombinationsIBA
11/2022 - 05/2020
2Peptides (Polypeptides)IBA
11/2022 - 09/2014
22,4-dinitrofluorobenzene sulfonic acidIBA
10/2022 - 01/2020
2LigandsIBA
01/2022 - 12/2021
2Silicon Dioxide (Silica)FDA LinkGeneric
12/2021 - 08/2019
2Verteporfin (Visudyne)FDA Link
12/2021 - 08/2019
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 08/2019
2Temozolomide (Temodar)FDA LinkGeneric
05/2020 - 01/2018
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 11/2019
2AntibodiesIBA
01/2019 - 01/2017
2Protein Isoforms (Isoforms)IBA
01/2019 - 01/2016
2PerforinIBA
01/2017 - 01/2013
2Biomarkers (Surrogate Marker)IBA
01/2017 - 06/2015
2Death Domain ReceptorsIBA
02/2014 - 05/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2024
1RANK LigandIBA
04/2024
1GlucocorticoidsIBA
04/2024
1Cysteine Proteinase InhibitorsIBA
11/2023
1NAD (NADH)IBA
10/2023
1EnzymesIBA
10/2023
1SodiumIBA
01/2023
1Myelin-Oligodendrocyte GlycoproteinIBA
11/2022
1EpitopesIBA
11/2022
1InflammasomesIBA
01/2022
1HydrogelsIBA
01/2022
1Inducible T-Cell Co-Stimulator ProteinIBA
01/2022
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1Collagen Type I (Type I Collagen)IBA
01/2022
1Biocompatible Materials (Biomaterials)IBA
01/2022
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2021
12- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
11/2021
1Glutens (Glutelin)IBA
03/2021
1Interferon-gamma (Interferon, gamma)IBA
03/2021
1InterleukinsIBA
03/2021
1Antigen-Antibody Complex (Immune Complex)IBA
03/2021
1Protein Glutamine gamma Glutamyltransferase 2IBA
03/2021
1Messenger RNA (mRNA)IBA
03/2021
1Tight Junction ProteinsIBA
03/2021
1GliadinIBA
03/2021
1Glia Maturation Factor (GMF)IBA
09/2020
1Bevacizumab (Avastin)FDA Link
05/2020
1Sirolimus (Rapamycin)FDA Link
05/2020
1Taxoids (Taxanes)IBA
02/2020
1Docetaxel (Taxotere)FDA Link
02/2020
1taxaneIBA
02/2020
16-bromo-2-naphthyl sulfate (BNS)IBA
01/2020

Therapy/Procedure

12Therapeutics
01/2024 - 01/2017
3Drug Therapy (Chemotherapy)
09/2020 - 02/2020
2Immunotherapy
11/2022 - 10/2020
2Photochemotherapy (Photodynamic Therapy)
12/2021 - 08/2019
2Injections
05/2020 - 09/2014
1Punctures
01/2022
1Ligation
01/2022
1Immunomodulation
01/2022
1Subcutaneous Injections
12/2021
1Transplantation
11/2021
1Total Parenteral Nutrition
05/2020